XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Series 1 Preferred
Preferred Stock
Preferred stock, beginning balance (in shares) at Dec. 31, 2020             452,000
Preferred stock, beginning balance at Dec. 31, 2020             $ 18,036
Preferred stock, ending balance (in shares) at Dec. 31, 2021             452,000
Preferred stock, ending balance at Dec. 31, 2021 $ 18,036           $ 18,036
Balance, beginning of period (in shares) at Dec. 31, 2020   8,385,650 67,746        
Balance, beginning of period at Dec. 31, 2020 (2,497) $ 84 $ (5,056) $ 543,561 $ (540,747) $ (339)  
Increase (Decrease) in Stockholders' Equity              
Share-based compensation 3,439     3,439      
Issuance of common stock upon vesting of restricted stock units (in shares)   111,375          
Issuance of common stock upon vesting of restricted stock units 0 $ 1   (1)      
Issuance of common stock and pre-funded warrants exercise, net of issuance costs (in shares)   0          
Issuance of common stock and pre-funded warrants exercise, net of issuance costs 32,908     32,908      
Extinguishment of private option liability 249     249      
Comprehensive loss $ (9,704)       (9,705) 1  
Balance, end of period (in shares) at Dec. 31, 2021 8,429,279 8,497,025 67,746        
Balance, end of period at Dec. 31, 2021 $ 24,395 $ 85 $ (5,056) 580,156 (550,452) (338)  
Preferred stock, ending balance (in shares) at Dec. 31, 2022             452,000
Preferred stock, ending balance at Dec. 31, 2022 18,036           $ 18,036
Increase (Decrease) in Stockholders' Equity              
Share-based compensation 2,609     2,609      
Issuance of common stock upon vesting of restricted stock units (in shares)   128,472          
Issuance of common stock upon vesting of restricted stock units 0 $ 1   (1)      
Issuance of common stock and pre-funded warrants exercise, net of issuance costs (in shares)   56,950          
Issuance of common stock and pre-funded warrants exercise, net of issuance costs 0 $ 1   (1)      
Comprehensive loss $ (24,989)       (24,973) (16)  
Balance, end of period (in shares) at Dec. 31, 2022 8,614,701 8,682,447 67,746        
Balance, end of period at Dec. 31, 2022 $ 2,015 $ 87 $ (5,056) $ 582,763 $ (575,425) $ (354)